Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Profit After Tax: 2018-2025

Historic Profit After Tax for Neurogene (NGNE) over the last 5 years, with Sep 2025 value amounting to -$21.0 million.

  • Neurogene's Profit After Tax fell 3.64% to -$21.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$85.1 million, marking a year-over-year decrease of 102.81%. This contributed to the annual value of -$75.1 million for FY2024, which is 106.91% down from last year.
  • According to the latest figures from Q3 2025, Neurogene's Profit After Tax is -$21.0 million, which was up 4.83% from -$22.0 million recorded in Q2 2025.
  • Over the past 5 years, Neurogene's Profit After Tax peaked at $13.7 million during Q4 2023, and registered a low of -$22.6 million during Q1 2025.
  • In the last 3 years, Neurogene's Profit After Tax had a median value of -$18.5 million in 2024 and averaged -$15.1 million.
  • Data for Neurogene's Profit After Tax shows a maximum YoY crashed of 242.92% (in 2024) over the last 5 years.
  • Over the past 3 years, Neurogene's Profit After Tax (Quarterly) stood at $13.7 million in 2023, then slumped by 242.92% to -$19.5 million in 2024, then fell by 3.64% to -$21.0 million in 2025.
  • Its last three reported values are -$21.0 million in Q3 2025, -$22.0 million for Q2 2025, and -$22.6 million during Q1 2025.